When inhibiting HYOU1 expression, it reduced the malignant behavior and stemness of the cancer cells, facilitated apoptosis, and made the MCTSs more sensitive to chemotherapy drugs in lung cancer. Here, HYOU1 is linked to lung carcinoma.